Cases
-
Latest cases
Unconditional approval for $3 billion merger between Chilean financial institutions Bicecorp and Grupo Security
-
Latest cases
Energy and climate transition: How to strengthen the EU’s competitiveness
-
Latest cases
Haier Smart Home secures unconditional clearance for Carrier Commercial Refrigeration acquisition under the new FSR regime
-
Latest cases
PBMs and Prescription Drug Distribution: An Economic Consideration of Criticisms Levied Against Pharmacy Benefit Managers
-
Latest cases
Compass Lexecon advised e& in the European Commission’s first in-depth merger review under the Foreign Subsidies Regulation
-
Latest cases
Compass Lexecon Client Ryan Cohen Defeats Class Certification in Multibillion-Dollar Securities Fraud Suit Involving Bed Bath & Beyond
Court Relies Heavily on “Credible and Clarifying” Testimony of Compass Lexecon Chairman Professor Daniel R. Fischel
-
Latest cases
STIHL prevails in appeal against Bundeskartellamt infringement decision on non-compete covenant
-
Latest cases
Compass Lexecon Client Smurfit Holdings Awarded $473 million by ICSID Tribunal
Showing 1–16 of 59 results
-
09 Oct 2024
Dennis W. Carlton, Mary Coleman, Nauman Ilias, Theresa Sullivan, and Nathan Wilson conducted a study, commissioned by Caremark, Express Scripts, and Optum Rx, that focuses on the role of pharmacy… -
13 Aug 2024
On August 1, 2024, AbbVie completed its $8.7 billion acquisition of Cerevel Therapeutics. The deal closed after a merger review by the U.S. Federal Trade Commission. A Compass Lexecon team led… -
03 Apr 2024
Compass Lexecon’s client Express Scripts defeated a motion for certification of putative classes of direct and indirect purchasers of the specialty drug Acthar. -
08 Jan 2024
On December 14, 2023, Pfizer completed its $43 billion acquisition of Seagen – the largest M&A deal in biopharma since 2019. The deal closed after merger reviews by competition authorities around… -
13 Sept 2023
Compass Lexecon worked closely with the merging parties on this matter, starting with a team advising Horizon on the merger (led by Compass Lexecon expert Mark Israel) and proceeding to the… -
22 Mar 2022
Dr. Nathan Wilson and Compass Lexecon were retained by Riverside Health System to provide economic analysis in support of their plan to build a new hospital in Isle of Wight County, Virginia. -
14 Mar 2022
On March 11, 2022, a jury in California delivered a unanimous verdict in favor of Compass Lexecon’s client Sutter Health in Sidibe et. al, v. Sutter Health, a Federal class action antitrust case… -
20 Dec 2021
Compass Lexecon provided economic advice and analysis in the $17 billion global acquisition of PPD, Inc by Thermo Fisher Scientific Inc. PPD is a contract research organisation and a lab service… -
02 Aug 2021
The Plaintiff in this unusual California state court holder’s action, Ahmed Hussein, claimed he planned to sell his large stake in Quality Systems Inc. (now known as NextGen Healthcare) after he… -
02 Mar 2021
On December 17, 2020, the U.S. District Court for the District of Kansas granted summary judgment in favor of Compass Lexecon’s client Mylan Inc. on antitrust claims brought by Sanofi-Aventis… -
Compass Lexecon Client Anthem Successfully Avoids $1.85 Billion Breakup Fee. This multi-year litigation stemmed from the failure of the $54 billion Anthem-Cigna merger in 2017.
-
Court Relies on Testimony of Compass Lexecon's Kenneth Lehn in ruling against Boston Scientific's MAE claim in Channel Medsystems merger dispute.
-
19 Aug 2019
Compass Lexecon supported GlaxoSmithKline plc (GSK) and Pfizer Inc. in their multi-billion dollar merger of their consumer healthcare businesses, providing crucial economic analyses for… -
17 Jan 2019
In January 2019, Solenis and BASF completed the creation of a joint venture combining their global paper and water chemicals businesses, with a pro forma sales value of approximately $3 billion. -
18 Nov 2018
In November 2018, the European Commission approved the $62 billion (£46 billion) acquisition of Shire by Takeda Pharmaceutical Company subject to remedies, after a Phase I investigation. The… -
Our professionals
Compass Lexecon’s staff includes more than 850 employees, including professional consultants, analysts, and practice support personnel that span 23 offices across the globe.